Form 8-K - Current report:
SEC Accession No. 0001615219-21-000070
Filing Date
2021-07-01
Accepted
2021-07-01 17:18:29
Documents
15
Period of Report
2021-07-01
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K flks-20210701.htm   iXBRL 8-K 41313
2 EX-4.01 salarius-formofwarranttopu.htm EX-4.01 79443
3 EX-5.01 salarius-51opinionflexwarr.htm EX-5.01 14134
7 GRAPHIC image_0.jpg GRAPHIC 28105
  Complete submission text file 0001615219-21-000070.txt   329690

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT flks-20210701.xsd EX-101.SCH 1924
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT flks-20210701_lab.xml EX-101.LAB 23892
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT flks-20210701_pre.xml EX-101.PRE 12541
8 EXTRACTED XBRL INSTANCE DOCUMENT flks-20210701_htm.xml XML 11438
Mailing Address 2450 HOLCOMBE BLVD SUITE J-608 HOUSTON TX 77021
Business Address 2450 HOLCOMBE BLVD SUITE J-608 HOUSTON TX 77021 346-772-0346
Salarius Pharmaceuticals, Inc. (Filer) CIK: 0001615219 (see all company filings)

EIN.: 465087339 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36812 | Film No.: 211067013
SIC: 2834 Pharmaceutical Preparations